BOARD OF DIRECTORS
Thomas N. Kelly
Chairman of the Board
Thomas Kelly serves as Managing Director of KMK & Associates LLC, a private equity firm with a wide range of interests from agriculture to manufacturing. He is also a Director of The Leaders Bank, headquartered in Oak Brook, Illinois. With diverse leadership roles in numerous companies and civic organizations, Mr. Kelly is a trusted and experienced leader known for his ability to anticipate and navigate business challenges with accountability and transparency. He serves on the Boards of the Donald P. and Byrd M. Kelly Foundation, which primarily supports Catholic education in the Chicago area. He attended the University of Kansas in Lawrence, and is an active alumnus serving as member of the President’s Advisory Council.
Current Board Positions: Managing Member of KMK & Associates LLC, Director of Leaders Bank, Director of Grandstand Sportswear and Glassware, Managing Member of 3840 Greenway Circle LLC, Director of Harger Woods Corporate Center LLC, Managing Member of D.P. Kelly & Associates, Director Of Elarasys Worldwide LLC, Director of Continental Community Holdings, Director and Secretary of Donald P. and Byrd M. Kelly Foundation.
Shareholding in Dignitana AB as of 17 May 2019: 30 327
Board Member and Chief Executive Officer
Before bringing his experience to the medical technology field, William Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).
Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015. He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017. He also serves as CEO of Dignitana S.r.l, which was registered in Italy in 2018. A native of New Jersey, Mr. Cronin is a graduate of Muhlenberg College in Pennsylvania and has a Master’s in Business Administration in Finance from the University of Texas Dallas.
Current Board Positions: Chairman, C3 Device Partners
Shareholding in Dignitana AB as of 17 May 2019: 4 245 739 through C3 Device Partners
Greg Dingizian is the Owner and CEO of his own holding company, Adma Förvaltnings AB. Greg has extensive experience from leading positions, including the duty as CEO of GOTIC AB, Wihl Sonesson AB, Victoria Park AB and HSB Malmö EK.för and several other companies. He has extensive experience from board work within a number of companies, e.g. as Chairman of the Board of Directors in Annehem Fastigheters AB, Victoria Park AB and Board member in over fifty other companies.
Current Board Positions: Board membership of Adma Förvaltnings AB and Kollektiva Innovation Studios AB
Shareholding in Dignitana AB as of 24 May 2019: 10 220 000 (8 720 000 through Adma Förvaltnings AB and 1,500,000 through Skandia Endowment)
Ingrid Atteryd Heiman
Ingrid Atteryd Heiman has worked with companies spanning the women’s health, food, pharmaceutical, biotech, life science, and financial services industries. Most recently, from 2014 to 2015 she served as Acting Chief Executive Officer of Ellen AB (Publ), a biotech company offering patented probiotic products treated to improve women’s health where she also has served as Chairman of the Board. Ms. Atteryd Heiman’s leadership experience includes services as Chief Executive Officer for three successful companies, several board chairman positions, and board member positions, primarily with those listed on OMX First North and Spotlight stock market which demand effective communication with the market and shareholders. She has a proven ability to successfully strategize business development and drive profit and growth. Through her years as a management consultant she has been involved in change management, efficiency optimization, strategy development, mergers, and acquisitions. Ms. Atteryd Heiman attended Lund University, where she obtained a bachelor degree in finance and B2B marketing, and Uppsala University where she obtained an MBA in International Business. She has also completed the StyrelseAkademien board member training.
Current Board Positions: Chairman of Doxa AB (Publ), Director of Redwood Pharma (Publ), Director of Parkinson Research Foundation.
Shareholding in Dignitana AB as of 17 May 2019: 10 000
Pontus Kristiansson is a strategy consultant with Altaverita AB. Pontus has more than 20 years’ experience as founder, CEO and Board executive of several startup and growth businesses. He started his career with the consumer goods marketing company Procter & Gamble and thereafter as a strategy consultant with McKinsey & Co before launching his first technology company 1999. Pontus holds a MSc in Engineering from Lund University LTH. He is also a climate impact investor and Chairman of the investment firm Realinvest AB. He has extensive experience from acting in leading positions and of Board work within a number of companies, e.g. as CEO and Board member of Kollektiva Innovation Studios AB, Vice President of Marketing at Rich Relevance Inc., Board member of IKANO Försäkring AB, CEO and Board member of Avail Intelligence AB, Business Development Consultant at Maersk Data Sverige AB and CEO of Absalon Group AB.
Current Board Position: Chairman of the Board of Realinvest AB.
Shareholding in Dignitana AB as of 17 May 2019: 8 000
Board Member and Deputy Managing Director
Mikael Wahlgren is Owner and Senior Legal Adviser of Linton & Wahlgren AB and has worked as General Counsel for Alfa Lavaland in-house counsel supporting several multinational Swedish and foreign listed companies including Skanska, ABB, Rolls-Royce and NCC. Mr. Wahlgren’s extensive legal expertise in Swedish and international commercial legal matters has earned him a reputation as one of the most respected and sought-out counsels in business today managing, organizing and supporting company leadership, Boards of Directors and other stakeholders with legal guidance, strategic thinking and risk awareness. He has completed the StryelseAkademien Chairmen training and EFL’s executive board member training and holds a Master of law degree from the University of Lund in Sweden.
Current Board Positions: Board Chairman of Gran Man AB.
Shareholding in Dignitana AB as of 17 May 2019: 10 000
Chief Executive Officer
Before bringing his experience to the medical technology field, Bill Cronin began his career in finance, starting with Shearson Lehman Brothers in New York in 1987 and then moving to Dallas in 1992 to work with Capital Institutional Services as their Head of International Sales and Trading. After leaving CIS in 1999, Mr. Cronin became President of Direct Trading Institutional, an early pioneer in high speed electronic trading, which was ultimately sold to Knight Capital Group (KCG: NYSE).
Mr. Cronin became involved with scalp cooling after his wife’s diagnosis with breast cancer in 2011. After her success with scalp cooling, together they founded Chemo Cold Caps, LLC, one of the largest US-based providers of manual scalp cooling solutions to patients. Mr. Cronin began working with Dignitana in 2014 as the company’s clinical trial was being completed, becoming COO of the US subsidiary after FDA clearance in 2015. He was appointed CEO of Dignitana Inc. in 2016 and of AB in November 2017. He also serves as CEO of Dignitana S.r.l, which was registered in Italy in 2018.
A native of New Jersey, Bill is a graduate of Muhlenberg College in Pennsylvania and has a Masters in Business Administration in Finance from the University of Texas Dallas.
Current Board Positions: Chairman, C3 Device Partners
President and Chief Operating Officer
James McKinney brings extensive experience and a proven track record in leadership and operations including physician relations and partnership, program design and implementation, financial performance and system integration.
Jim joined Dignitana in June 2016 as a healthcare consultant. He was appointed COO in November 2016, and President in March 2018. His prior leadership roles include CEO of Clinical Partners and HB Anesthesia Groups and Division President of Iasis, President and COO of Leland Medical, and President and CEO of Brim Healthcare. He also serves as a healthcare consultant to Catholic Healthcare Systems and Catholic Relief Services.
Chief Financial Officer
Mary Hatcher has more than 20 years of broad, practical experience in diverse industries including retail and telecommunications, after key roles in finance and investor relations at Blockbuster, 7-Eleven and Excel Communications. She has a proven ability to impact business growth and manage through changing and challenging situations and has significant experience leading financial transactions, debt restructuring, strategic negotiations and cost reduction.
Vice President Marketing and Investor Relations
Melissa brings to Dignitana more than 25 years of experience in marketing, communications, event planning and sales. A graduate of Vanderbilt University with a degree in International Communications, her expertise is in building strong customer relationships via traditional and digital marketing strategies. Prior to joining Dignitana, she served as Executive Director of the American Advertising Federation Dallas and directed marketing and sales for myFootpath, an education technology start-up in Chicago. She previously worked in sales for Brinker International, in clinical services at Children’s Medical Center Dallas, and in account management at Spier Advertising NY.
Vice President Clinical Oncology Services
Josephine Divers brings extensive clinical oncology nursing background to the Dignitana team. She is a licensed registered nurse with 25 years’ experience in professional and collaborative patient care. Josie spent 20 years dedicated to oncology nursing with a specialization in breast cancer for the past 15 years. Prior to joining Dignitana, she served as a Registered Clinical Oncology Nurse at Baylor/Sammons Cancer Center. Her research and clinical trial experience includes published literature in Cancer Medicine, Journal of Oncology Nursing, as well as various findings presented at the national Oncology Nursing Society Congress.
Vice President Quality and Regulatory Affairs
Darren has over twenty-eight years experience working with class I, II, and III medical device companies such as Johnson and Johnson, GlaxoSmithKline and Thermo Fisher Scientific. His past work includes time in research and development and managing departments including production, quality assurance and quality control, sales, regulatory affairs, purchasing and warehousing. For the past several years he has worked as a consultant helping global medical device companies meet the demanding regulations of various governmental bodies.
Group Vice President Sales
Bill has worked in sales and product development for over 30 years, including roles with the automotive aftermarket division with Dow Chemical in Switzerland, South Africa and Detroit, Michigan, as well as sales for Expo Marketing, Inc. and Engineered Adhesive Systems, Inc.. He has worked with scalp cooling for over five years, initially in sales for Chemo Cold Caps, a company providing manual gel caps for scalp cooling.
Please note that the content of this website is not intended as professional medical or healthcare advice and should not be construed as a substitute for professional healthcare advice, or services from a qualified professional healthcare provider familiar with your unique situation. This content is intended solely as a general product and corporate information.
10925 Estate Lane, Suite 185
Dallas, TX 75238
226 60 Lund, Sweden
+46 46 16 30 90